A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma

Xiaoyan Liu, Jesse J. Swen, Meta H. M. Diekstra, Epie Boven, Daniel Castellano, Hans Gelderblom, Ron H. J. Mathijssen, Sita H. Vermeulen, Egbert Oosterwijk, Kerstin Junker, Max Roessler, Kristin Alexiusdottir, Asgerdur Sverrisdottir, Marius T. Radu, Valentin Ambert, Tim Eisen, Anne Warren, Cristina Rodriguez-Antona, Jesus Garcia-Donas, Stefan BohringerKarel K. M. Koudijs, Lambertus A. L. M. Kiemeney, Brian I. Rini, Henk-Jan Guchelaar

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)2350-2356
Number of pages7
JournalClinical Cancer Research
Volume24
Issue number10
DOIs
Publication statusPublished - 15 May 2018

Keywords

  • LUNG-CANCER
  • PD-L1 EXPRESSION
  • PROGNOSIS
  • COMMON
  • SUSCEPTIBILITY
  • METAANALYSIS

Cite this

Liu, X., Swen, J. J., Diekstra, M. H. M., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H. J., Vermeulen, S. H., Oosterwijk, E., Junker, K., Roessler, M., Alexiusdottir, K., Sverrisdottir, A., Radu, M. T., Ambert, V., Eisen, T., Warren, A., Rodriguez-Antona, C., Garcia-Donas, J., ... Guchelaar, H-J. (2018). A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma. Clinical Cancer Research, 24(10), 2350-2356. https://doi.org/10.1158/1078-0432.CCR-17-2815